Business
India
India
Elara initiates coverage on Alkem, Eris, IPCA and Mankind. Check ratings and targets
Elara has initiated coverage on four pharmaceutical stocks, assigning Buy, Accumulate and Reduce ratings. Alkem Laboratories emerged as its top pick for margin recovery, while Eris Lifesciences and Mankind Pharma could benefit from portfolio expansion, acquisitions and deleveraging. Elara retained a…
Continue Reading on Economic Times - Markets
This article is aggregated from Economic Times - Markets. Click below to read the full story.
Times of India - Business
The Guardian - Business
Economic Times
Bloomberg